Clotting Disorders

A collection of features and news articles published in ASH Clinical News related to clotting disorders.

Europe Poised to Approve Hydroxyurea for Sickle Cell Disease

Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Medicines Agency (EMA) grant marketing authorization to hydroxyurea for the...

FDA Alerts Patients About Blood Clot and Mortality Risk With Tofacitinib

The U.S. Food and Drug Administration (FDA) has issued a Safety Announcement for the Janus kinase (JAK) inhibitor tofacitinib after a required postmarketing trial...

Xarelto Manufacturers Settle Lawsuits Over Bleeding Risks

Johnson & Johnson and Bayer, the manufacturers of rivaroxaban (sold as Xarelto), have agreed to pay $775 million to settle thousands of lawsuits over...

FDA Approves Caplacizumab-yhdp for Acquired TTP

Caplacizumab-yhdp, a bivalent anti–von Willebrand factor nanobody, was approved for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with...

Planes, Trains, and VTEs

Simple recommendations can help mitigate risk for travel-related blood clots In November 2011, hematologist Suely Rezende, MD, PhD, deplaned from a flight from Lisbon to...

SHARE